Computer-aided diagnosis (CADx) systems have begun a successful transition from academic research to commercial implementation. FDA (Food & Drug Administration) approval of CADx for PAP (Peroxidase-Antiperoxidase) smear reading in 1995 and for breast cancer detection in 1998 were major milestones in this process. As agency experience with these devices has increased, a consensus is emerging concerning factors to be considered in the evaluation required during the approval process. Key elements determining the nature of the proof of safety and effectiveness required by the agency include the intrinsic level of risk associated with the device and the medical condition that it is meant to address, the precise claims made for the device and the degree of oversight exercised over its use. The agency expects that an increasing number of CADx devices will be submitted to it in the future and that guidelines will have to be formulated to assist manufacturers in navigating the approval process.


    Access

    Check access

    Check availability in my library

    Order at Subito €


    Export, share and cite



    Title :

    The evaluation of computer-aided diagnosis systems: an FDA perspective


    Contributors:
    Brown, D.G. (author)


    Publication date :

    2001-01-01


    Size :

    531499 byte




    Type of media :

    Conference paper


    Type of material :

    Electronic Resource


    Language :

    English



    The Evaluation of Computer-Aided Diagnosis Systems: An FDA Perspective

    Brown, D. G. | British Library Conference Proceedings | 2001


    Computer-aided fault diagnosis

    Automotive engineering | 1985


    Automated Computer Aided Diagnosis and Simulation

    Ali, A.-K. / Boyd, M. A. / Joseph, S. et al. | British Library Conference Proceedings | 1997


    Computer-aided headlamp evaluation

    Schmidt,C. / Volkswagen,Wolfsburg,DE | Automotive engineering | 1990


    Computer-Aided Headlamp Evaluation

    Schmidt, Christian | SAE Technical Papers | 1990